Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
11/2011
11/24/2011US20110288067 Pyrrolopyrazine Kinase Inhibitors
11/24/2011US20110288051 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
11/24/2011US20110287112 Prostate cancer progression inhibitor and progression inhibition method
11/24/2011US20110287067 Reinforced adhesive complex coacervates and methods of making and using thereof
11/24/2011US20110287065 Nanoparticulate cinacalcet compositions
11/24/2011US20110287063 Methods for prevention and treatment of inflammation using anti-chemokine antibodies
11/24/2011US20110287048 Antigen Specific Tregs and related compositions, methods and systems
11/24/2011US20110287040 Materials and methods for treatment of inflammation
11/24/2011US20110287023 High Affinity Antibodies Against HMGB1 and Methods of Use Thereof
11/24/2011US20110286959 Copolymers for suppression of autoimmune diseases, and methods of use
11/24/2011US20110286918 Immunotherapy of autoimmune disorders using antibodies which target b-cells
11/24/2011CA2799820A1 Posology and administration of glucocorticoid based compositions
11/24/2011CA2792669A1 Long - acting formulations of insulins
11/23/2011EP2387995A1 Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith
11/23/2011EP2387412A1 Methods for increasing adiponectin
11/23/2011EP1671649B1 Dipeptidyl peptidase IV inhibitors for treating diabetic patients with sulfonylurea secondary failure
11/23/2011EP1492780B1 5-substituted 1,1-dioxo-¬1,2,5 thiazolidine-3-one derivatives as ptpase 1b inhibitors
11/23/2011EP1467976B1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
11/23/2011EP1385527B2 Use of 2-alpha-cyano-4-alpha, 5-alpha-epoxyandrostan-17-beta-ol-3-one derivatives for lowering levels of serum cortisol and for the treatment of clinical conditions associated thereof
11/23/2011EP1362105B1 Anti-interferon-alpha antibodies
11/23/2011CN102256618A Combination of an insulin and a glp-1 agonist
11/23/2011CN102250098A Pyrazinones compound
11/23/2011CN102250071A Pyrazole compounds useful as protein kinase inhibitors
11/23/2011CN102247546A Prescription for relieving exterior syndrome and dispelling heat
11/23/2011CN102247471A Application of rehmannia root water extract to preparing estrogen medicament
11/23/2011CN101326184B 二杂环咪唑基化合物 Two heterocyclic imidazole compound
11/23/2011CN101244202B Chinese medicine oral administration solid preparations, preparation, quality control method and uses thereof
11/23/2011CN101130567B Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
11/22/2011US8063081 Aryl carbonyl derivatives as therapeutic agents
11/22/2011US8063037 Progesterone receptor modulators
11/22/2011US8063031 Implants and methods for treating inflammation-mediated conditions of the eye
11/22/2011US8062652 Compositions and methods for treating precocious puberty
11/22/2011CA2571760C New 2-substituted d-homo-estra-1,3,5(10)-trienes as inhibitors of 17.beta.-hydroxysteroid dehydrogenase type 1
11/22/2011CA2509151C Derivatives of aryl-quinazoline/aryl-2-amino-phenyl methanone which promote the release of parathyroid hormone
11/22/2011CA2489902C Thiazole derivatives as phosphodiesterase iv inhibitors
11/22/2011CA2455392C Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same
11/17/2011WO2011141713A1 New bicyclic compounds as pi3-k and mtor inhibitors
11/17/2011WO2011095535A3 Pregnane compounds condensed in position 16,17 with a pyrolidine ring with glucocorticoid activity
11/17/2011US20110281951 Compositions and methods for treating amyloidosis
11/17/2011US20110281879 Sulfonyl containing compounds as cysteine protease inhibitors
11/17/2011US20110281878 INHIBITORS OF p38
11/17/2011US20110281857 Pi3k/mtor kinase inhibitors
11/17/2011US20110281836 Silent desensitizers of neuronal NACHR and methods of use thereof
11/17/2011US20110281832 Organic compounds
11/17/2011US20110281822 Aromatic compounds having sphingosine-1-phosphonate (s1p) receptor activity
11/17/2011US20110281800 Recombinant fusion proteins to growth hormone and serum albumin
11/17/2011US20110281798 Methods for Lowering Plasma Glucagon with Exendins and Exendin Agonist Analogs
11/17/2011US20110280908 Multimeric protein toxins to target cells having multiple identifying characteristics
11/17/2011US20110280871 Methods for prevention and treatment of inflammation using anti-chemokine antibodies
11/17/2011US20110280855 Vitamin c compositions
11/17/2011US20110280840 Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
11/17/2011US20110280830 Albumin Fusion Proteins
11/16/2011EP2386291A1 Vaginally administrable progesterone-containing tablets and method for preparing same
11/16/2011EP1962826B1 Method for weight reduction
11/16/2011EP1487458B1 Multi-substituted selective androgen receptor modulators and methods of use thereof
11/16/2011CN102241680A Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
11/16/2011CN102241657A Synthesis of isoflavone compound through Stille crossed coupling reaction
11/16/2011CN102240388A Ginger extract and preparation method and applications thereof
11/16/2011CN101897927B Medicinal composition for treating hyperthyroidism and preparation method thereof
11/16/2011CN101304999B Non-steroidal compounds useful as glucocorticoid receptor modulators
11/16/2011CN101212973B 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
11/16/2011CN101171234B Dihydropyridine derivatives
11/15/2011US8058441 For control fertility, contraception, breast cancer, prostate cancer and endometriosis; modulating activity of the follicle stimulating hormone (FSH) receptor; 1-Acetyl-6-(tert-butoxycarbonyl)amino-4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethylquinoline
11/15/2011US8058314 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
11/15/2011US8058283 7H-pyrido[3,4-D]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors
11/15/2011US8058280 Substituted thieno[2,3-d]pyrimidin-2,4-dione compounds and uses thereof
11/15/2011US8057825 Krill extracts for treatment of cardiovascular diseases
11/15/2011CA2429979C Treatment of statin side effects
11/10/2011WO2011140161A1 Benzofuranyl analogues as gpr119 modulators
11/10/2011WO2011139992A1 Aromatic-cationic peptides and uses of same
11/10/2011WO2011138380A1 Pharmaceutical formulations comprising pioglitazone and linagliptin
11/10/2011WO2011047837A3 Melt-granulated cinacalcet
11/10/2011US20110275716 Composition and method for treatment of diabetes
11/10/2011US20110275684 Novel benzotriazole derivatives useful for the treatment of cns disorders
11/10/2011US20110275678 New Pyridine Derivatives as Leptin Receptor Modulator Mimetics
11/10/2011US20110275637 Piperazine derivatives and their use as leptin receptor modulators
11/10/2011US20110275629 Pyridazino-pyridinone Compounds and Methods of Use
11/10/2011US20110275601 Very low-dosed solid oral dosage forms for hrt
11/10/2011US20110274708 Short-form human md-2 as a negative regulator of toll-like receptor 4 signaling
11/10/2011US20110274704 Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
11/10/2011CA2795105A1 Pharmaceutical formulations comprising pioglitazone and linagliptin
11/09/2011EP2385064A2 Agents disrupting a growth factor complex
11/09/2011EP2385063A2 Growth factor complex
11/09/2011EP2384198A2 Pharmaceutical compositions and methods of treating neurological insults
11/09/2011EP1343508B1 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis
11/09/2011EP1328624B1 B7-like molecules and uses thereof
11/09/2011CN102234281A Pyrimidine-fused cyclic derivative
11/09/2011CN102233086A Health care traditional Chinese medicine for improving sub-health and raising essence, energy and spirit of men
11/09/2011CN102233078A Use of medicinal composition in preparation of medicine for regulating and improving microenvironment of pancreas islet
11/09/2011CN102233075A Use of medicinal composition in preparation of medicine for improving disorder of carbohydrate metabolism by regulating adenosine monophosphate -activated protein kinase (AMPK)-glucose transporter type 4(GLUT4)
11/09/2011CN102233074A Application of medicine composition in preparing functional medicines for protecting islet belta cells
11/09/2011CN102233059A Chinese medicinal composition for regulating female estrogen level and delaying senility and preparation method
11/09/2011CN102232995A Preparation method of total flavonoids in medicago sativa L.
11/09/2011CN102232956A Compound for preventing and treating metabolic diseases and application thereof
11/09/2011CN101703486B Novel flutamide tablets and method for preparing same
11/08/2011US8053472 Quantity of acetyl L-carnitine to be administered is 0.1 to 2 g/day, while the dose of biotin is 1 to 8 mg/day
11/08/2011US8053408 Methods for treating obesity using fibroblast growth factor-like polypeptides
11/08/2011CA2528312C Methods of managing the symptoms of premenstrual syndrome
11/08/2011CA2399100C Purified lh
11/03/2011WO2011136361A1 Peptide for improving in vivo stability of physiologically active substance or the like and physiologically active substance with improved in vivo stability
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 290